News of the index components SMI

Index

SMI

CH0009980894

Market Closed - Swiss Exchange 11:31:51 2024-07-05 am EDT			5-day change	1st Jan Change
12,006 ^PTS	-0.52%		+0.10%	+7.80%

Jul. 05	Swiss Equities Slide as European Political Jitters Resurface	MT
Jul. 05	Swiss Stocks Reverse Two-Session Winning Streak	DJ

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kuehne+Nagel Sets Up New US Logistics Facility for Sézane KNIN	Jun. 20	MT
SWISS REINSURANCE COMPANY : Buy rating from JP Morgan SREN	Jun. 20	ZD
Roche Launches First Clinically Approved Test for B-cell Lymphoma ROG	Jun. 20	MT
Roche Launches New Highly-Sensitive Test to More Easily Diagnostic Patients Who May Have B-Cell Lymphoma ROG	Jun. 20	CI
GIVAUDAN AG : Berenberg reaffirms its Neutral rating GIVN	Jun. 19	ZD
GIVAUDAN AG : Jefferies maintains a Sell rating GIVN	Jun. 19	ZD
Holcim : Environmentally sustainable European Patent Office building renovated with ECOPact and ECOCycle® LHN	Jun. 19	PU
Roche: collaboration agreement with Ascidian Therapeutics ROG	Jun. 18	CF
Roche Teams Up With Ascidian Therapeutics for RNA Gene Editing Deal ROG	Jun. 18	DJ
Roche partners with Ascidian Therapeutics to develop gene therapies ROG	Jun. 18	RE
Ascidian Therapeutics Enters Collaboration with Roche for Discovery and Development of RNA Exon Editing Therapeutics Targeting Neurological Diseases ROG	Jun. 18	CI
Roche: approval for digital pathology system ROG	Jun. 18	CF
GIVAUDAN AG : JP Morgan remains Neutral GIVN	Jun. 18	ZD
ROCHE HOLDINGS AG : Goldman Sachs gives a Sell rating ROG	Jun. 17	ZD
ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ROG	Jun. 17	ZD
ROCHE HOLDINGS AG : Gets a Neutral rating from Barclays ROG	Jun. 17	ZD
ROCHE HOLDINGS AG : JP Morgan gives a Sell rating ROG	Jun. 17	ZD
Roche: positive phase III data in lymphoma ROG	Jun. 17	CF
Roche's Blood Cancer Combo Reduces Risk of Death in Late-stage Study ROG	Jun. 17	MT
Transcript : Roche Holding AG - Shareholder/Analyst Call ROG	Jun. 16
Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma ROG	Jun. 15	BU
Roche?s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma ROG	Jun. 15	CI
NESTLE : UBS reiterates its Buy rating NESN	Jun. 14	ZD
Roche: collaboration agreement in colon cancer ROG	Jun. 14	CF
GIVAUDAN AG : Deutsche Bank reiterates its Neutral rating GIVN	Jun. 14	ZD
NESTLE : Bernstein reaffirms its Neutral rating NESN	Jun. 14	ZD
Kuehne+Nagel Launches Contract Logistics Center in Germany KNIN	Jun. 14	MT
Carbonfuture, Swiss Re Sign 70,000 MT Biochar Offtake Deal --OPIS SREN	Jun. 13	DJ
Environmental, Social and Governance Factors: Sika Committed to Sustainable Performance June 2024 SIKA	Jun. 13	PU
Kuehne und Nagel International : Bio Gianfranco Sgro 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Stefan Paul 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Yngve Ruud 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Sarah Kreienbühl 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Michael Aldwell 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Martin Kolbe 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Markus Blanka-Graff 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Marc Pfeffer 2024 KNIN	Jun. 13	PU
Kuehne und Nagel International : Bio Hansjoerg Rodi 2024 KNIN	Jun. 13	PU
BNP Paribas Exane Lowers Price Target on Nestle NESN	Jun. 13	MT
The women shaping coffee: How the Nescafé Plan empowers female farmers NESN	Jun. 13	PU

No results for this search

2 3 4 5 6

Headlines

Swiss Stocks Reverse Two-Session Winning Streak

July 05, 2024 at 12:25 pm EDT

Indices: CAC relaxes, Merval soars

July 02, 2024 at 03:57 am EDT

Rankings

Highest SMI increases
PARTNERS GROUP HOLDING AG	+1.42%
LONZA GROUP AG	+0.68%

The sharpest declines in SMI.
ROCHE HOLDING AG	-0.04%
SWISS RE LTD	-0.23%
NESTLÉ S.A.	-0.43%
GEBERIT AG	-0.52%
HOLCIM LTD	-0.84%
ALCON INC.	-0.99%
KUEHNE UND NAGEL INTERNATIONAL AG	-1.31%
GIVAUDAN SA	-1.44%